Canadian Medical Association

2019

Smoking and E-cigarettes

September 5, 2019

CMA response: Health Canada consultation on vaping products labelling and packaging regulations

The CMA supports tighter restrictions on nicotine levels in vaping products and health warnings on packaging similar to those used for tobacco products. It also recommends all vaping substances and ingredients be labelled. 
Cannabis

September 3, 2019

CMA response: Health Canada consultation on potential market for cannabis health products

Recommendation by CMA that all cannabis health products that make health claims, including those with CBD, be reviewed thoroughly for efficacy, safety and quality.  CMA also recommends strict packaging requirements and childproof containers to ensure consumer safety.
Access to care Climate Change and Health

August 2, 2019

CMA submission: Acting on Today’s and Tomorrow’s Health Care Needs

The CMA’s pre-budget submission to the House of Commons Standing Committee on Finance provides recommendations to improve access to primary care, better prepare for and mitigate the health impacts of a changing climate, and more
Smoking and E-cigarettes

May 24, 2019

CMA response: Health Canada consultation on reducing youth access and appeal of vaping products

The CMA reiterates its calls for all vaping ads to be banned in public spaces, for regulations restricting the flavours and nicotine levels in vaping products, and for Health Canada to develop a youth-focused communication campaign about the health impacts of vaping
Smoking and E-cigarettes

March 22, 2019

CMA Response: Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products

The CMA calls for vaping to be banned in public spaces, to prevent marketing to youth, and for health warnings to be placed on all vaping products
Cannabis

February 20, 2019

CMA response: Health Canada consultation on edible cannabis, extracts and topicals

To ensure safety, the CMA supports restrictions on product potency and the use of additives, and the prohibition of edibles in appealing flavours and shapes. It also calls for plain, childproof packaging, with clear content, potency and health warnings.

2018

Smoking and E-cigarettes

December 14, 2018

CMA Response: Health Canada’s consultation on new health-related labelling for tobacco products

The CMA reiterates its long-standing support for tobacco products being sold in standardized packages, with health warning labelling, and supports similar labelling on individual cigarettes
Cannabis Opioids

December 4, 2018

CMA response: Health Canada consultation on Canadian drugs and substances strategy

The CMA supports a public health approach to substance use issues, and a comprehensive national strategy to address the harms associated with psychoactive drugs
Pharmacare

October 2, 2018

CMA submission: Implementation of national pharmacare

In this submission to the Advisory Council on the Implementation of National Pharmacare, the CMA urges the federal government to explore universal coverage for 125 essential medicines
Smoking and E-cigarettes

September 6, 2018

CMA brief on plain packaging: Health Canada consultation

The CMA supports Health Canada’s proposal to enforce standardized packaging for tobacco products with specific recommendations for packaging appearance and dimensions
Opioids

August 14, 2018

CMA response: Consultation on Regulatory Amendments regarding Tramadol

To protect Canadians’ health and safety, the CMA advises tramadol be placed on Schedule 1 of the Controlled Drugs and Substances Act
Opioids

July 18, 2018

CMA response: Consultation on Restriction of Marketing and Advertising of Opioids

The CMA supports Health Canada’s efforts to restrict the ability of drug manufacturers to advertise opioids to health care practitioners
Chronic Disease Prevention

June 6, 2018

Canada's Food Guide

The CMA calls for a modern, practical Canada Food Guide based on sound nutritional evidence in a submission to the House of Commons Standing Committee on Health
Chronic Disease Prevention

April 23, 2018

CMA letter to Health Canada

The CMA issues a letter to Health Canada calling for front-of-packaging labelling on food and beverages
Seniors Care

March 8, 2018

Meeting the Demographic Challenge: Investments in Seniors Care

The CMA’s pre-budget submission to the House of Commons Standing Committee on Finance proposes that the federal government fund a share of the health care costs associated with Canada’s aging population
Smoking and E-cigarettes

February 15, 2018

CMA recommendations to the House of Commons for Bill S-5

The CMA submits recommendations to the House of Commons regarding Bill S-5 to support population health, protect youth and restrict the promotion of vaping products
Medical Assistance in Dying

February 13, 2018

Federal monitoring of medical assistance in dying regulations

The CMA provides input to Health Canada on its proposed regulations for the federal monitoring of medical assistance in dying in Canada, supporting the intent and highlighting areas for consideration, including the need for clear definitions and reasons for ineligibility
Cannabis

January 19, 2018

Proposed Approach to the Regulation of Cannabis

The CMA makes a submission to Health Canada on the proposed cannabis regulations — focusing on prevention, harm reduction, and other measures consistent with a public health approach

2017

Cannabis

December 17, 2017

Excise Duty Framework for Cannabis Products

The CMA weighs in on the federal government’s proposed excise duty framework for cannabis products, highlighting the importance of a public health approach to legalization and recommending tax revenue from cannabis be earmarked to fund prevention, education and treatment initiatives
Opioids

November 7, 2017

CMA submission on Non-Prescription Availability of Low-Dose Codeine Products

In the interest of promoting public health and patient safety, the CMA endorses the requirement that all products containing low-dose codeine be sold by prescription only
Seniors Care

October 26, 2017

Advancing Inclusion and Quality of Life for Seniors

The CMA recommends ways to improve seniors’ quality of life as part of a study by the House of Commons Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities
Seniors Care

September 21, 2017

CMA submission: Social Equity and Increasing Productivity

The CMA’s 2018 pre-budget submission to the House of Commons Standing Committee of Finance includes recommendations to improve health care system productivity and effectiveness for Canada’s growing seniors population
Cannabis

August 18, 2017

Bill C-45: CMA submission to the House of Commons Standing Committee on Health

The CMA’s submission to the House of Commons Standing Committee on Health recommends the legalization age for cannabis be changed to 21 and that the government undertake a multi-facted public health strategy to minimize the health risks associated with cannabis consumption
Cannabis

August 17, 2017

Bill C-45: CMA submission to the Senate Standing Committee, Social Affairs, Science & Technology

To support deliberations of the House of Commons Standing Committee on Health, the CMA submits a brief on Bill C-45, the Cannabis Act, promoting a broad legal-regulatory framework
Pharmaceuticals

June 28, 2017

CMA response: Patented Medicines Regulations Consultations

The CMA responds to Health Canada consultations on patented medicines regulations, calling for revisions to bring transparency and clarity to price setting of patented medicines
Pharmacare

June 28, 2017

CMA response: Patented Medicines Regulations Consultations

The CMA calls for revisions to Patented Medicines Prices Review Board regulations to ensure: a) transparency and clarity in setting patented medicine prices; b) the lowest possible costs; and c) continued access to a wide variety of pharmaceutical products
Chronic Disease Prevention

June 14, 2017

CMA support for Bill S-228

The CMA’s support for Bill S-228: An Act to amend the Food and Drugs Act (prohibiting food and beverage marketing directed at children)
Medical Assistance in Dying

May 15, 2017

Federal Monitoring and Reporting Regime for MAID

In a submission to Health Canada, the CMA recommends features of a federal monitoring and reporting regime for medical assistance in dying, including privacy protection and a clear definition of what constitutes a request
Smoking and E-cigarettes

April 7, 2017

CMA recommendations to the Senate Standing Committee on Social Affairs, Science and Technology for Bill S-5

The CMA submits recommendations to the Senate Standing Committee on Social Affairs, Science and Technology regarding Bill S-5 to support population health, protect youth and restrict the promotion of vaping products
Opioids

April 6, 2017

CMA submission on the study of Bill C-37: An Act to amend the Controlled Drugs and Substances Act

The CMA makes recommendations to the Senate Committee on Legal and Constitutional Affairs about Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts
Smoking and E-cigarettes

April 5, 2017

Consultation on the renewal of Federal Tobacco Control Strategy

Information and the CMA’s position on smoking cessation submitted as part of Health Canada’s consultation on the renewal of the Federal Tobacco Control Strategy
Social Determinants of Health

February 28, 2017

CMA recommendations for Effective Poverty Reduction Strategies

The CMA recommends poverty reduction strategies in support of a study by the House of Commons Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities
Smoking and E-cigarettes

January 10, 2017

CMA response to Health Canada's Proposed Order Amending the Schedule to the Tobacco Act

The CMA registers its support for Health Canada’s Proposed Order Amending the Schedule to the Tobacco Act (Menthol) prohibiting menthol in cigarettes, blunt wraps and cigars

2016

Opioids

October 18, 2016

CMA statement to the House of Commons Standing Committee on Health

Dr. Jeff Blackmer, CMA Vice-president of Medical Professionalism, speaks before the House of Commons Standing Committee on Health about Canada’s escalating public health crisis related to problematic opioid and fentanyl use
Cannabis

August 29, 2016

Legalization, Regulation and Restriction of Access to Marijuana

In a submission to the Government of Canada Task Force on Marijuana Legalization and Regulation, the CMA calls for a broad public health policy approach for cannabis legalization and regulation in Canada
Smoking and E-cigarettes

August 12, 2016

Health Canada’s Consultation on “Plain and Standardized Packaging”

The CMA recommends guidelines for regulating the appearance, shape and size of tobacco packaging and products in response to Health Canada’s consultation on the matter
Pharmacare

June 1, 2016

National Pharmacare in Canada: Getting There from Here

In a submission to the House of Commons Standing Committee on Health, the CMA calls for federal leadership and financial contribution to support a national pharmacare program on par with Canada’s Medicare program
Pharmaceuticals

June 1, 2016

National Pharmacare in Canada: Getting There from Here

The CMA submits background to support a federal study on the development of a national pharmacare program, underscoring the need for federal government leadership and financial support
Access to care

May 12, 2016

CMA submission: Reducing barriers to physician mobility and for a more uniformed health care system in Canada

The CMA puts forward a series of recommendations for the federal government to help reduce barriers to mobility of physicians and enhance uniform access to care
Opioids

March 19, 2016

CMA response: Consultation on the Prescription Drug List: Naloxone

In response to Health Canada’s consultation on the prescription drug list, the CMA advocates for increased access to naloxone for emergency treatment of opioid overdose outside hospitals
Pharmaceuticals

January 20, 2016

Regulatory Framework for the Mandatory Reporting of Adverse Drug Reactions and Medical Device Incidents by Provincial and Territorial Healthcare Institutions

The CMA recommends improvements to Canada’s adverse drug reactions reporting system in response to a Health Canada consultation

2015

Medical Assistance in Dying

October 19, 2015

CMA formal submission to the Federal External Panel on assisted dying

In its submission to the Federal External Panel on Options for a Legislative Response to Carter vs. Canada, the CMA puts forward its position on the forthcoming legislative and regulatory framework to govern assisted dying in Canada, calling for a national, pan-Canadian approach
Pharmaceuticals

June 8, 2015

CMA response: Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)

The CMA calls for enhancements and revised guidance in response to Health Canada’s public consultation on the Guide to New Authorities under Bill C-17 Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law)
Chronic Disease Prevention

June 2, 2015

Obesity in Canada: Causes, Consequences and the Way Forward

In a submission to the Senate Standing Committee on Social Affairs, Science and Technology, the CMA shares the physician perspective on the causes and consequences of obesity in Canada and recommends ways to help Canadians make healthy food choices
Opioids

May 14, 2015

CMA submission to the Senate Standing Committee on Legal and Constitutional Affairs on Bill C-2: An Act to Amend the Controlled Drugs and Substances Act

The CMA presents its concerns with Bill C-2 before the Senate Standing Committee on Legal and Constitutional Affairs, including that the new legislation could make it harder to create new supervised consumption sites
Access to care

March 25, 2015

Accessibility: the solution lies in cooperation

A joint brief from the CMA and the Québec Medical Association on improving access to health care in the province of Quebec

2014

Medicine and Technology

December 8, 2014

CMA submission to Advisory Panel on Healthcare Innovation

A CMA submission to the Advisory Panel on Healthcare Innovation highlights five innovations to support Canada’s growing seniors population, including supportive living models that use technology to help seniors stay in their homes
Smoking and E-cigarettes

November 27, 2014

CMA submission to the House of Commons Study on E-Cigarettes

Information submitted on the current regulatory status and health implications of e-cigarettes, along with recommendations to support the House of Commons Health Committee study on e-cigarettes
Smoking and E-cigarettes

November 10, 2014

CMA submission to Health Canada

The CMA supports Health Canada’s proposed order to amend the schedule to the Tobacco Act to prohibit the use of certain flavoring additives in cigars — and recommends the ban be extended to menthol in all tobacco products
Opioids

October 28, 2014

CMA submission to the House of Commons Standing Committee on Public Safety and National Security on Bill C-2: An Act to Amend the Controlled Drugs and Substances Act

Concerns about the potential of Bill C-2 impede the creation of new supervised consumption sites feature in the CMA’s submission to the House of Commons Standing Committee on Public Safety and National Security
Opioids

August 26, 2014

CMA response on Tamper Resistance under the Controlled Drugs and Substances Act

The CMA advocates for regulations requiring products containing certain controlled substances to be tamper-resistant as a condition for sale in Canada
Seniors Care

August 6, 2014

Improving Seniors Care in an Era of Surplus

The CMA’s 2014-2015 pre-budget consultation submission calls on the federal government to invest strategically in long-term health care sustainability due to Canada’s aging population
Medical Assistance in Dying

July 27, 2014

Factum of the Intervener, the Canadian Medical Association

The CMA submits an affidavit and factum on medical assistance in dying to the Supreme Court of Canada to support the Court’s judgment in Carter v. Canada, which challenged the provision in the Criminal Code prohibiting assisted suicide
Cannabis

July 11, 2014

Proposed amendments to the Marijuana for Medical Purposes Regulations

The CMA responds to Health Canada’s proposed regulatory amendments governing medicinal cannabis, raising concerns about the scarcity of evidence for using cannabis as medical therapy as well as other objections to the existing regulatory framework
Climate Change and Health

June 2, 2014

CMA submission: Bill C-422 An Act respecting a National Lyme Disease Strategy

In this submission, the CMA recognizes the importance of reporting and monitoring infectious diseases in Canada that emerge in relation to global climate change
Cannabis

May 27, 2014

The Health Risks and Harms Associated with the Use of Marijuana

In a submission to the House of Commons Standing Committee on Health, the CMA outlines health risks and harms associated with cannabis use to support the committee’s study on the topic and advocates for a public health approach to psychoactive substance use
Smoking and E-cigarettes

May 15, 2014

Higher rate now: Why excise tax on tobacco is long overdue for an increase

The CMA calls for an increase in the excise tax on tobacco in a submission to the Standing Senate Committee on Banking, Trade and Commerce, citing research that suggests price increases reduce the number of cigarettes smoked and smoking prevalence rates
Opioids

March 26, 2014

CMA submission on the Senate study on prescription pharmaceuticals

In support of the Senate Committee on Social Affairs, Science and Technology study on prescription pharmaceuticals in Canada, the CMA recommends ways for the federal government to address the unintended consequences of prescription pharmaceuticals and support public health, quality care and patient safety
Opioids

March 17, 2014

CMA submission on the Review of Controlled Drugs and Substances Act

The CMA’s response to Health Canada’s consultation on the Controlled Drugs and Substances Act and its regulations recommends new measures and mechanisms for improving public health and safety, including enhancements to controlled substance approval, labelling and safety monitoring

2013

Opioids

November 27, 2013

The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada

The CMA supports the House of Commons Standing Committee on Health study on the government’s role in addressing prescription drug abuse in Canada with background on the issue and recommendations for tackling the issue, including national strategies for reducing misuse and promoting optimal prescribing
Social Determinants of Health

November 6, 2013

Healthier Generations for a Prosperous Economy: CMA 2013-2014 pre-budget consultation submission

In a pre-budget consultation submission to the Standing Committee on Finance, the CMA recommends federal investment in the social determinants of health, a seniors care strategy and other priorities
Social Determinants of Health

April 25, 2013

CMA submission: Motion 315 (Income Inequality)

The CMA recommends measures to combat income inequality in Canada as part of submission to the House of Commons Standing Committee on Finance
Cannabis

February 28, 2013

CMA response: Health Canada’s Medical Marijuana Regulatory Proposal

A CMA submission to Health Canada’s Office of Controlled Substances calls attention to the lack of evidence-based information about the drug’s use as medical therapy and recommends support for scientific research, knowledge translation and other activities to meet physicians’ information needs

2012

Social Determinants of Health

November 1, 2012

A More Robust Economy through a Healthier Population: CMA 2012-2013 pre-budget submission

The CMA’s pre-budget submission recommends ways the federal government can help transform Canada’s health care system and improve the health of Canadians, including recognizing the implications of the social determinants of health on system demand
Social Determinants of Health

May 31, 2012

CMA submission to the House of Commons Standing Committee on Finance Study of Bill C-38

CMA President Dr. Jeffrey Turnbull presents the physician perspective on why policy-makers need to pay greater attention to the social determinants of health in an address to the House of Commons Standing Committee on Finance
Access to care

May 9, 2012

CMA submission: A Doctor for Every Canadian − Better Planning for Canada's Health Human Resources

The CMA underscores the need for a pan-Canadian approach to ensure adequate health human resources, in support of a sustainable health care system

2011

Chronic Disease Prevention

October 17, 2011

Chronic Diseases Related to Aging

The CMA presents to the House of Commons Standing Committee on Health about aging-related chronic diseases, recommending a comprehensive national chronic disease management program to reduce the burden of chronic disease on patients, the health care system and society

2010

Access to care

August 13, 2010

Healthy Canadians lead to a Productive Economy: Canadian Medical Association 2011 pre-budget consultation submission

A series of recommendations for federal investments to makes the health care system more effective, accountable and sustainable, and better meet Canadians’ needs

1999

Smoking and E-cigarettes

March 12, 1999

CMA response to Health Canada’s Discussion Papers

The CMA assesses Health Canada’s proposed labelling requirements for tobacco products and options for tobacco promotion regulations, recommending a total ban on advertising and promoting tobacco products at points of sale and other measures